Doyle announces $750,000 award for Stratatech

Doyle announces $750,000 award for Stratatech

Madison, Wis. – One week after securing a federal research grant, Stratatech Corp. has received a $750,000 state grant award to help develop new, genetically-enhanced human skin substitutes to heal wounds.
Stratatech, which last week landed a $1.45 million grant from the National Institute on Aging, has been awarded the state grant based on its potential to achieve life-saving breakthroughs, according to Gov. Jim Doyle.
“Biotechnology is a competitive industry and Wisconsin still has a lead, but we need to continue to support these efforts in a significant way at the state level,” Doyle said in a release.
Stratatech is a regenerative medicine company focused on the development of cell-based, tissue-engineered products that promote the healing of chronic skin ulcers. The company, founded in 2000, is developing products that have been genetically enhanced to express natural, human wound-healing factors that reduce infection and improve blood flow to the wound.
The state grant is from the Technology Development Fund program within the Wisconsin Department of Commerce.
Related stories
Stratatech Corp. lands another federal research grant
Venture-backed firms could become eligible for federal SBIR grants
Stratatech Receives another NIH Grant
Stratatech Receives $4 Million Federal Grant